Evidence map›Paper›PMID 30020996›Full record

ArticlePLoS pathogens2018

Mitochondrial DNA is critical for longevity and metabolism of transmission stage Trypanosoma brucei.

Caroline E Dewar, Paula MacGregor, Sinclair Cooper, Matthew K Gould, Keith R Matthews, Nicholas J Savill, Achim Schnaufer

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. MonomorphicMicrobial genomics · 2021
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Caroline E DewarCentre for Immunity, Infection and Evolution, Institute of Immunology & Infection Research, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0002-0107-6985
Paula MacGregorCentre for Immunity, Infection and Evolution, Institute of Immunology & Infection Research, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0003-0919-3745
Sinclair CooperCentre for Immunity, Infection and Evolution, Institute of Immunology & Infection Research, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0002-0371-1591
Matthew K GouldCentre for Immunity, Infection and Evolution, Institute of Immunology & Infection Research, University of Edinburgh, Edinburgh, United Kingdom.
Keith R MatthewsCentre for Immunity, Infection and Evolution, Institute of Immunology & Infection Research, University of Edinburgh, Edinburgh, United Kingdom.
Nicholas J SavillCentre for Immunity, Infection and Evolution, Institute of Immunology & Infection Research, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0002-9769-6168
Achim SchnauferCentre for Immunity, Infection and Evolution, Institute of Immunology & Infection Research, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0003-2132-5560
Centre for Immunity, Infection and Evolution · GB

Funding

Medical Research Council G0600129Medical Research Council G0601295Medical Research Council MR/L019701/1Wellcome Trust 103740/Z/14/Z
6 · The paper itself

Abstract

The sleeping sickness parasite Trypanosoma brucei has a complex life cycle, alternating between a mammalian host and the tsetse fly vector. A tightly controlled developmental programme ensures parasite transmission between hosts as well as survival within them and involves strict regulation of mitochondrial activities. In the glucose-rich bloodstream, the replicative 'slender' stage is thought to produce ATP exclusively via glycolysis and uses the mitochondrial F1FO-ATP synthase as an ATP hydrolysis-driven proton pump to generate the mitochondrial membrane potential (ΔΨm). The 'procyclic' stage in the glucose-poor tsetse midgut depends on mitochondrial catabolism of amino acids for energy production, which involves oxidative phosphorylation with ATP production via the F1FO-ATP synthase. Both modes of the F1FO enzyme critically depend on FO subunit a, which is encoded in the parasite's mitochondrial DNA (kinetoplast or kDNA). Comparatively little is known about mitochondrial function and the role of kDNA in non-replicative 'stumpy' bloodstream forms, a developmental stage essential for disease transmission. Here we show that the L262P mutation in the nuclear-encoded F1 subunit γ that permits survival of 'slender' bloodstream forms lacking kDNA ('akinetoplastic' forms), via FO-independent generation of ΔΨm, also permits their differentiation into stumpy forms. However, these akinetoplastic stumpy cells lack a ΔΨm and have a reduced lifespan in vitro and in mice, which significantly alters the within-host dynamics of the parasite. We further show that generation of ΔΨm in stumpy parasites and their ability to use α-ketoglutarate to sustain viability depend on F1-ATPase activity. Surprisingly, however, loss of ΔΨm does not reduce stumpy life span. We conclude that the L262P γ subunit mutation does not enable FO-independent generation of ΔΨm in stumpy cells, most likely as a consequence of mitochondrial ATP production in these cells. In addition, kDNA-encoded genes other than FO subunit a are important for stumpy form viability.

Indexed as

DNA, MitochondrialAnimalsDNA, KinetoplastHost-Parasite InteractionsMiceTrypanosoma brucei bruceiTrypanosomiasis, AfricanDNA, KinetoplastDNA, Mitochondrial

Identifiers

PMID30020996
PMCPMC6066258
OpenAlexW2883427563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.